1988-92, University of California, Los Angeles, B.Sc. (HON), Molecular, Cellular, and Developmental Biology
1992-96, University of California, San Francisco School of Medicine, M.D.
1996-97, University of California, San Francisco, Intern, General Surgery
1997-02, University of California, San Francisco, Resident, General Surgery
2002-03, University of California, San Francisco, Chief Resident, General Surgery
2003-04, University of California, San Francisco, Fellow, Interventional Radiology
2004-05, University of California, San Francisco, Fellow, Vascular Surgery
2005-06, University of California, San Francisco Dept. of Epidemiology and Biostatistics, Postdoctoral Fellow, Clinical Research
American Board of Surgery
American Board of Surgery, Vascular Surgery
Carotid artery disease
Lower extremity arterial and venous disorders
Thoracic and abdominal aortic aneurysms and dissections
Gender differences in vascular surgical outcomes
Hemodynamic changes after aortic stent-graft placement
Inflammatory response and kidney injury after complex endovascular procedures
Spinal perfusion after endovascular thoracoabdominal aortic aneurysm repair
Dr. Jade Hiramoto is a vascular surgeon with expertise in both minimally invasive endovascular techniques as well as open surgical interventions. Her clinical areas of expertise include open and endovascular repair of thoracic and abdominal aortic aneurysms and dissections, carotid artery disease, renovascular disease, and lower extremity arterial and venous disorders.
Dr. Hiramoto earned her medical degree from the University of California, San Francisco School of Medicine. She completed her residency in general surgery, as well as fellowships in both interventional radiology and vascular surgery at the University of California San Francisco. She is an assistant professor of surgery at UCSF.
Dr. Hiramoto's research involves both clinical and translational research, with a special interest in the abnormal inflammatory response and kidney injury after complex endovascular aortic procedures. She is also interested in gender-based differences in the treatment and outcomes of vascular disease. Dr. Hiramoto is an investigator on several clinical trials, including the use of endovascular stent-grafts for treatment of abdominal and thoracic aortic aneurysms, the use of carotid stents for prevention of stroke, and the measurement of pressure changes in the aorta after placement of stent-grafts to treat aneurysms.
Fernandez CC, Sobel JD, Gasper WJ, Vartanian SM, Reilly LM, Chuter TA, Hiramoto JS. Standard off-the-shelf versus custom-made multibranched thoracoabdominal aortic stent grafts. J Vasc Surg. 2016 May; 63(5):1208-15. View in PubMed
Han SM, Wu B, Eichler CM, Reilly LM, Vartanian SM, Conte MS, Hiramoto J. Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease. Vasc Endovascular Surg. 2015 Apr; 49(3-4):69-74. View in PubMed
Vartanian SM, Robinson KD, Ofili K, Eichler CM, Hiramoto JS, Reyzelman AM, Conte MS. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service. Ann Vasc Surg. 2015 Apr; 29(3):534-42. View in PubMed
Premprabha D, Sobel J, Pua C, Chong K, Reilly LM, Chuter TA, Hiramoto JS. Visceral branch occlusion following aneurysm repair using multibranched thoracoabdominal stent-grafts. J Endovasc Ther. 2014 Dec; 21(6):783-90. View in PubMed
Sobel JD, Vartanian SM, Gasper WJ, Hiramoto JS, Chuter TA, Reilly LM. Lower extremity weakness after endovascular aneurysm repair with multibranched thoracoabdominal stent grafts. J Vasc Surg. 2015 Mar; 61(3):623-9. View in PubMed
Grenon SM, Cohen BE, Smolderen K, Vittinghoff E, Whooley MA, Hiramoto J. Peripheral arterial disease, gender, and depression in the Heart and Soul Study. J Vasc Surg. 2014 Aug; 60(2):396-403. View in PubMed
Hiramoto JS, Katz R, Weisman S, Conte M. Gender-specific risk factors for peripheral artery disease in a voluntary screening population. J Am Heart Assoc. 2014; 3(2):e000651. View in PubMed
Walker JP, Hiramoto JS, Gasper WJ, Auyang P, Conte MS, Rapp JH, Lovett DH, Owens CD. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease. J Vasc Surg. 2014 Jul; 60(1):176-83. View in PubMed
Grenon SM, Chong K, Alley H, Nosova E, Gasper W, Hiramoto J, Boscardin WJ, Owens CD. Walking disability in patients with peripheral artery disease is associated with arterial endothelial function. J Vasc Surg. 2014 Apr; 59(4):1025-34. View in PubMed
Garimella PS, Ix JH, Katz R, Chonchol MB, Kestenbaum BR, de Boer IH, Siscovick DS, Shastri S, Hiramoto JS, Shlipak MG, Sarnak MJ. Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study. Atherosclerosis. 2014 Mar; 233(1):91-6. View in PubMed
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.